Focalin Capsule, Extended Release
Pricing Report NDC 66758-241-31

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Focalin Xr (NDC 66758-241-31) is $5.42512 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 14, 2026.

As a a human prescription drug provided by Sandoz Inc, this medication is distributed in a 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$5.42512
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jan 14, 2026
Billable Units
30 EA
Estimated Package Price
$162.75
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
66758-241-31
Description
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $2.03643 (Effective: Jun 17, 2026)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2026, the NADAC wholesale price for (NDC ) has moved within a range of $5.42512 to $5.42512 per EA. Over this the last few weeks period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Historical Note: This product currently has limited pricing history. Trends will be available as more monthly survey data is collected by CMS.
Date Unit Price Unit Source Method Rate
Jan 14, 2026 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 14, 2026 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 14, 2026 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 14, 2026 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 14, 2026 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 14, 2026 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Jan 14, 2026 $5.42512 EAC/I - Chain or Independent PharmacyCode 4B - Brand

Pricing Methodology Legend

  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026